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Abstract 
Kidney diseases are complicated and can be fatal. Dialysis and transplantation are the only survival solutions to the 
patients suffering from kidney failures. Both hemodialysis and peritoneal dialysis are risky, due to the possibility of 
infection and these are expensive and time consuming. The development of simple and reliable technique for the 
clearance of creatinine and urea from the body is an important part of biotechnology. We have synthesized an iron 
nanoparticle (INP) and studied its binding with creatinine and urea. The DLS, TEM, AFM, FT-IR and Powder-XRD studies 
demonstrate strong binding of creatinine and urea to the nanoparticles. This finding may be helpful if it is used in the 
dialysis technologies. The proposed method may substantially decrease dialysis time and improve its quality in terms 
of urea and creatinine clearances.
© 2015 Banerji and Pramanik. This article is distributed under the terms of the Creative Commons Attribution 4.0 International 
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made.
Background
Chronic kidney disease (CKD) is becoming increasingly 
common and can lead to chronic kidney failure when 
both the kidneys stop functioning totally (Dousdampa-
nis et al. 2014; Rahbari-Oskoui et al. 2014). The kidneys 
are filtration units which purify blood from the waste 
by-products including creatinine and urea. Eventually 
in the case of kidney failure these and other waste mol-
ecules accumulate in the body and dialysis becomes the 
only solution (Kim and Takayama 2015; Nassar and Ayus 
2001). To date no proper medicine has emerged for the 
treatment of CKD, with the exception of strong immuno-
suppressant drugs which actually prolong the kidney 
failure rather than effect a cure (Nassar and Ayus 2001; 
Dalal et al. 2011). Dialysis is associated with a high risk of 
infection and is costly (Nassar and Ayus 2001).
Among various nanoparticles, iron nanoparticles 
(INPs) have been found to be biologically compatible, 
and can be coated with biomolecules, drugs, enzymes, 
or antibodies to increase their functionalities for bio-
sensing applications (Xie et  al. 2010; Todd et  al. 2014; 
Bachelet-Violette et  al. 2014; Verma et  al. 2014). It is 
cheap, non-toxic, and easy to prepare (Tromsdorf et  al. 
2009; Banerji et al. 2012a, b). Now a days INPs have been 
widely used for targeted drug delivery, immobilization of 
enzymes, biosensor, and different environmental analy-
sis (Verma et al. 2014). They are extensively used as MRI 
contrast agents due to their ability to shorten T2* relaxa-
tion times for the liver, spleen, and bone marrow (Na 
et al. 2009). The surface properties of INPs allow to func-
tionalize with small organic molecules by their various 
functional groups for wide range of applications (Wein-
gart et  al. 2013). The nano-bio composite of INPs and 
chitosan have been reported for the detection of glucose, 
urea, phenolic compounds and ferritin (Lin et al. 2015). 
However, immobilization of biomolecules onto surface 
charged super paramagnetic INPs are of great inter-
est because of magnetic behavior of their bio conjugates 
(Wahajuddin 2012).
Recently, we have initiated a program to synthesize 
iron-nanoparticles (INPs) with high affinity towards 
nitrogen containing compounds (Banerji et  al. 2012a). 
With an aim to test the use of the INPs for the treat-
ment of CKD patients, we have studied the binding 
affinity of creatinine and urea using various techniques 
like DLS, TEM, AFM, FT-IR and Powder-XRD. Here we 
disclose our preliminary results on the binding studies 
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of creatinine and urea on INPs. One future possibility of 
this study is to utilize the strong affinity binding of creati-
nine and urea into the dialysis technology. It is proposed 
that in the presence of nanoparticles the rate of osmosis 
may be much higher compared to normal case leading 
to better dialysis. The present study thus may be the first 
foot-step towards achieving that major goal.
Methods
Materials
FeCl2·4H2O, FeCl3·6H2O, urea and creatinine were pur-
chased from Sigma Aldrich. Sodium hydroxide (NaOH), 
hydrochloric acid (HCl), citric acid and sodium citrate 
were obtained from Merck. Carbon coated copper grid 
for TEM study was purchased from Allied Scientific 
Product, USA. ASTM V1 Grade Ruby Mica sheet for 
AFM study was purchased from Micafab India Pvt. Ltd., 
Chennai, India. Water obtained from Sartorius Stedim 
biotech machine was used for all the experiments.
Synthesis of iron‑nanoparticles
First 1 g (0.005 mol) FeCl2·4H2O was dissolved in 20 ml 1 
(M) HCl and then 2.7 g (0.01 mol) FeCl3.6H2O was added 
to the solution and stirred under magnetic stirrer. Then 2 
(M) NaOH solution was added until the black precipitate 
appeared and the pH also become basic. This black pre-
cipitate was then separated and washed three times with 
30 ml deionized and deoxygenated water. After that 20 ml 
citric acid-sodium citrate buffer was added to disperse the 
INPs. These INPs were washed by repeated cycles (four 
times) of centrifugation and dried in air. Millipore water 
was used throughout to disperse the nanoparticles as 
needed for characterization as well as further studies.
Synthesis of iron‑nanoparticle‑creatinine 
and iron‑nanoparticle‑urea conjugates (Chen and Kimura 
1999; Brust et al. 1994)
Creatinine and urea bind to the INPs by noncovalent 
interaction (van der Waals forces) between the INPs and 
creatinine/urea. Creatinine/urea solution of concen-
tration 0.5  mg/ml was prepared by dissolving 50  mg of 
creatinine/urea in 100 ml millipore water. For the conju-
gation of creatinine/urea onto iron nanoparticles (INPs), 
10 ml of this solution and 20 mg of as-synthesized INPs 
were taken into a flat-bottomed conical flask with glass 
stopper. The flask was sealed with parafilm and stirred 
at 60 °C for 24 h. The unbound creatinine and urea were 
separated by centrifugation at 30,000  rpm for 30  min. 
The conjugated INPs were washed by repeated cycles of 
centrifugation and dried under vacuum.
Dynamic light scattering (DLS)‑based zeta‑potential 
measurements (Kuypers et al. 2015)
To obtain an idea about the size distributions and stabil-
ity of INPs, creatinine conjugated INPs and urea conju-
gated INPs, DLS experiments (model: Zetasizer Nano 
Z, Malvern Instruments Ltd, United Kingdom) were 
carried out with their aqueous suspension at 20  °C. The 
scattered lights were collected at a 90o angle. Data were 
acquired and analyzed by Precision Deconvolve program. 
For a typical DLS experiment, 200 μl (conc. 2 mg/ml) of 
a sample solution was slowly pipetted into a clean quartz 
micro-cuvette.
TEM sample preparation and imaging (Banerji et al. 2014)
A Tecnai G2 Spirit TEM operating at 80 kV was used to 
study the morphology of the INPs and conjugated INPs. 
10 µl (conc. 2  mg/ml) of the nanoparticle solution was 
placed on a 300-mesh carbon coated copper grid (form-
var foil upon copper grids) and the excess samples were 
removed cautiously by tissue paper. No additional stain-
ing was done.
AFM sample preparation and imaging (Banerji et al. 2012a)
10  µl (conc. 2  mg/ml) of the nanoparticle solution was 
deposited on a freshly cleaved muscovite Ruby mica 
sheet 10 min after that the sample was dried under vac-
uum. AC-mode atomic force microscopy was performed 
by using a Pico Plus 5500 AFM (Agilent Technologies, 
Inc., Santa Clara, CA, USA) with a piezo scanner maxi-
mum range of 9 μm. Microfabricated silicon cantilevers 
of 225  μm in length with a nominal spring force con-
stant of 21–98  N/m were used from nanosensors. Can-
tilever oscillation frequency was tuned into resonance 
frequency. The cantilever resonance frequency was 150–
300 kHz. All the images (512 × 512 pixels) were captured 
with a scan size between 0.5 and 5 μm at the scan speed 
rate of 0.5 rpm. The images were processed by flattening 
using Pico view software (Molecular Imaging Inc., Ann 
Arbor, MI, USA).
FT‑IR experiment (Banerji et al. 2013)
The FT-IR spectra of the samples were recorded on a 
JASCO FT/IR 4200 spectrometer using the (KBr) disc 
technique. For FT-IR measurements all the samples are 
used in their solid powder form. The solid creatinine, 
urea, creatinine conjugated INPs and urea conjugated 
INPs were mixed with KBr separately in a clean glass 
mortar and compressed to obtain a pellet. Background 
spectra were obtained with a KBr pellet for each sample. 
JASCO software was used for data processing.
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Powder X‑Ray diffraction study
X-Ray diffraction studies of INPs, creatinine tagged INPs 
and urea tagged INPs were carried out with a Scifert 
X-ray diffractometer (C 3000) using ‘Cu ka’ radiation. The 
data collection was recorded in the range of 2θ = 5–60° 
with a step of 0.02o and 2 s/step.
Results and discussion
DLS study
The average diameters and the size distribution polydis-
persity index (PDI) of the samples were determined by 
DLS. DLS experiments were carried out with their aque-
ous solutions and the results showed that the mean par-
ticle size of INPs (intensity average) are 8.66 ± 4 nm with 
PDI 0.23, creatinine tagged INPs are 9.26 ±  3  nm with 
PDI 0.29 and that of urea tagged INPs are 9.16 ± 4 nm 
with PDI 0.34. The zeta potential distribution of INPs are 
negative charged to −38.8  mV, creatinine tagged INPs 
with a negative charge −23.5  mV and of urea tagged 
INPs with a negative charge −21.4  mV in water, which 
are sufficient to keep the particles from interacting with 
each other and therefore maintain a stable particle size 
of the sample. The decrease in zeta potential of INPs is 
observed due to the coating of creatinine/urea over INPs 
which minimizes the free surface energy by restructur-
ing the surface (Nel et  al. 2009). The resulting negative 
charges in INPs, creatinine tagged INPs and urea tagged 
INPs are attributed to negative surface charge on them.
TEM and AFM imaging
The transmission electron microscopy (TEM) images of 
INPs (Fig. 1a, b), creatinine conjugated INPs (Fig. 1c) and 
urea conjugated INPs (Fig. 1d) are depicted. It is observed 
from the figure that the size of INPs is almost uniform 
in nature and most of them are approximately spherical 
in size with diameter 6 nm. Figure 1 c, d show the size of 
creatinine conjugated INPs and urea conjugated INPs and 
are approximately of 7–9 nm. The increase in size strongly 
Fig. 1 a, b TEM images of INPs; c TEM images of creatinine conjugated INPs and d TEM images of urea conjugated INPs
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indicates the binding of creatinine and urea onto INPs. In 
AFM images the INPs (Fig.  2) are of nearly spherical in 
size with 6 nm diameter and having tendency of agglom-
eration, whereas creatinine conjugated INPs (Fig.  3a, b) 
and urea conjugated INPs (Fig. 3c, d) are with nearly 9 nm 
diameter. It has been also observed that INPs are prone 
to quick agglomeration. But to the contrary the creatinine 
conjugated INPs and urea conjugated INPs are stable to 
coagulation because of its lack of free reactive surface.
Interpretation of FT‑IR spectra
Interaction and binding of creatinine to the INPs were 
confirmed by taking FT-IR spectra of creatinine and 
creatinine tagged INPs. The FTIR spectrum of bare 
INPs does not show any characteristic peaks (Sharifi 
et al. 2013). Figure 4a shows FT-IR spectra of creatinine 
(black) and creatinine tagged INPs (red) in the region 
of 450–3500 cm−1. The fundamental modes of FT-IR in 
creatinine are the stretching and bending of N–H bond 
of the amino group present (Jerônimo et  al. 2012). The 
creatinine molecule possesses one free NH2 group and 
hence one expects one symmetric and one asymmetric 
N–H stretching vibrations. In all the primary aromatic 
amines the N–H stretching frequency occurs in the 
region 3300–3500  cm−1. The FTIR spectrum of creati-
nine showed characteristic peaks at 3257 and 3057 cm−1, 
respectively due to one symmetric and one asymmet-
ric N–H stretching vibrations (Jerônimo et  al. 2012). 
Broad bands indicate the presence of the amine form in 
the structure. The observed low values of bands are due 
to the participation in the H-bonding interactions. The 
band observed at 1671 cm−1 is due to the C=O stretch-
ing mode (Pezzaniti et  al. 2001). The NH2 out-of-plane 
deformation frequency is found in the 665–900  cm−1 
region (NH2 wag) for primary amines. Here the bands 
observed at 841 and 812  cm−1 are as the fundamental 
due to the wagging modes of the amino group. The C–H 
stretching wave numbers of N bonded methyl group are 
lower than methyl groups attached to carbon atom. The 
N-methyl symmetric C–H stretch occurs from 2805 to 
2780 cm−1 (Trendafilova et al. 1991). The bands at 2806 
and 2980  cm−1 in the solid phase were assigned to the 
C–H symmetric and asymmetric stretching modes of 
N-CH3 group, respectively. Some measurable differ-
ences in the IR spectra of pure creatinine and creati-
nine tagged INPs were detected. When creatinine binds 
with INPs the N–H stretching vibration of NH2 group is 
much affected and found to shift to higher wavenumbers 
because when the aromatic ring nitrogen binds to metal, 
the ring stretching wave numbers shift to higher wave 
numbers. In the bound condition one symmetric and one 
asymmetric N–H stretching vibrations occur at 3282 and 
3093  cm−1, indicating the presence less intermolecular 
hydrogen bonding. The observed bands corresponding 
to stretching vibrations γ←(NH2) and their wave num-
bers are found to be higher in value in case of creatinine 
tagged INPs than those of free creatinine and the −NH2 
group of creatinine involved in interaction with the INPs. 
Thus for the creatinine-conjugated INPs the structural 
heterogeneity became less and the possibility of inter-
molecular hydrogen bonding among different conform-
ers decreased. In the spectrum of urea (Fig.  4b) the 
Fig. 2 a, b AFM images of INPs
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asymmetric and symmetric N–H stretching bands can 
be found at 3440 and 3347  cm−1, respectively (Fischer 
and McDowell 1960). The band observed at 1682  cm−1 
is due to the C=O stretching mode. The corresponding 
vibration wave numbers for urea tagged INPs analogues 
are found at 3458 and 3353 cm−1 (Jung et al. 2004). Solid 
urea showed characteristic but broad urea bands when 
it did not bind to the INPs, however most of the FT-IR 
bands were sharper in the urea tagged INPs.
X‑ray diffraction study
X-ray diffraction studies produce the long range 
order produced as a consequence of very short range 
interactions. Figure  5 shows the X-ray diffraction pat-
terns of INPs, creatinine tagged INPs and urea tagged 
INPs.
For all the reflections correspond to INPs are very 
close to those of the standard data of Fe3O4 alone in pow-
der diffraction PDF card (JCPDS No. 82n1533) (Banerji 
et  al. 2012a). The presence of sharp and intense peaks 
confirmed the formation of highly crystalline INPs. The 
appearance of sample diffraction peaks at 2θ =  30.16°, 
35.70°, 43.33°, 53.60°, 57.10°, and 62.9° corresponded 
to the (220), (311), (400), (422), (511) and (440) crystal 
planes of Fe3O4 respectively, which indicated that the 
resulting particles were Fe3O4, with structures of cubic 
Fig. 3 a, b AFM images of creatinine conjugated INPs and c, d AFM images of urea conjugated INPs
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crystal (Banerji et  al. 2012). The X-ray diffraction pat-
tern and the main diffraction angles of creatinine tagged 
INPs agreed with the data of creatinine. However, for 
creatinine tagged INPs the intensities of the diffraction 
peaks at 2θ = 7.4°, 19.9°, 25.8°, and 27.5° are due to the 
(100), (200), (300), (012) and (013) planes of creatinine 
Fig. 4 a FT-IR of creatinine (black) and creatinine tagged INPs (red) and b FT-IR of urea (black) and urea tagged INPs (red)
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molecule (Sakata et  al. 2005). In case of urea tagged 
INPs the main diffraction angles agreed with the data of 
urea. However, the intensities of the diffraction peak at 
2θ = 22.6°, 33.1° and 65.5° are corresponds to the (110), 
(210) and (212) planes of urea (Fernández-Bertrán et al. 
2000). For creatinine tagged INPs and urea tagged INPs 
the indices corresponding to Fe3O4 are present. This 
reveals that the modification of INPs surface with cre-
atinine or urea does not result in the phase change of 
Fe3O4.
Fig. 5 XRD patterns of urea tagged INPs (black), creatinine tagged INPs (blue) and INPs (red)
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Application and future scopes
The INPs are nontoxic in nature to the human body which 
was earlier reported by our group (Banerji et al. 2012a). 
The binding of creatinine and urea into the INPs may be 
useful for the dialysis patients if this basic research is suc-
cessfully translated and applied into dialysis technology. 
Dialysis is based on the principle of osmosis and the rate 
of osmosis may be enhanced by employing INPs exter-
nally into the dialyzer. It is proposed that the INPs may 
capture more creatinine and urea from the blood thereby 
shifting the equilibrium more towards right. Hence it is 
believed that urea and creatinine clearance may improve, 
this way by making the dialysis more efficient.
Conclusion
All the analytical techniques (DLS, TEM, AFM, FT-IR, 
and Powder-XRD) have unambiguously proved the 
strong binding of creatinine and urea with INPs. In our 
laboratory, currently we are pursuing the dialysis study 
and will disclose the result in due time. In the present 
study we have successfully tagged creatinine and urea to 
the INPs. In this communication, the detailed binding 
studies are disclosed.
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